Kura Oncology, Inc. Quarterly Depreciation in USD from Q4 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Kura Oncology, Inc. quarterly/annual Depreciation history and growth rate from Q4 2014 to Q1 2024.
  • Kura Oncology, Inc. Depreciation for the quarter ending March 31, 2024 was $234K, a 13.6% increase year-over-year.
  • Kura Oncology, Inc. annual Depreciation for 2023 was $849K, a 11.9% increase from 2022.
  • Kura Oncology, Inc. annual Depreciation for 2022 was $759K, a 36% increase from 2021.
  • Kura Oncology, Inc. annual Depreciation for 2021 was $558K, a 188% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $234K +$28K +13.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q1 2023 $206K +$29K +16.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 $177K +$69K +63.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $108K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2018 $5K -$3K -37.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2017 $8K $0 0% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q1 2016 $8K +$5K +167% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q1 2015 $3K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 $1K Aug 22, 2014 Dec 31, 2014 10-K 2016-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.